chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient began to feel very tired and short of breath with her heart bounding. Her heart rate was 143 at that time. She laid down for 15 min and her heart rate was 90.  One hour later she was evaluated in ER.  Her BP was 116/86, not normal for her.  Tests were done and she was told to go home, take tylenol and nap.
Patient described experiencing "itching all over" that started about 30 minutes after vaccine administration.  Also she reported feeling very tired starting about 6 hours after vaccine administration.
Left upper arm goes numb periodically and when it does my left hand is weak. Feels like the muscle in my upper arm is asleep.
At 1:00am on 8/26, I was woken with severe stomach pains.  I got up to go to the bathroom, and lost consciousness, fainting on my bathroom floor. My spouse revived me, and when I stood up I vomited. I then had diarrhea and my entire body broke out in a heavy sweat. The following morning, I experienced headaches and neck pain from falling, and felt very tired.
Patient was discharged from Hospital to local Medical care Facility (SNF). Prior to discharge she was to receive her "first" dose of a COVID vaccine. She was given the Pfzier Bivalent booster instead. She should have gotten a monovalent.
Cryptogenic CVA that began at the time listed in form resulting in emergency transport via ambulance to an emergency room where the clot busting drug TNK was administered, and then resulting in a three day ICU admission
Severe itching skin lesions developed over the lower abdomen initially, but spread to the neck, trunk and four limbs afterwards; Severe itching skin lesions developed over the lower abdomen initially, but spread to the neck, trunk and four limbs afterwards; Skin rash; This spontaneous case was reported by a consumer and describes the occurrence of SKIN LESION (Severe itching skin lesions developed over the lower abdomen initially, but spread to the neck, trunk and four limbs afterwards), PRURITUS (Severe itching skin lesions developed over the lower abdomen initially, but spread to the neck, trunk and four limbs afterwards) and RASH (Skin rash) in a 40-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN LESION (Severe itching skin lesions developed over the lower abdomen initially, but spread to the neck, trunk and four limbs afterwards) and PRURITUS (Severe itching skin lesions developed over the lower abdomen initially, but spread to the neck, trunk and four limbs afterwards). an unknown date, the patient experienced RASH (Skin rash). At the time of the report, SKIN LESION (Severe itching skin lesions developed over the lower abdomen initially, but spread to the neck, trunk and four limbs afterwards), PRURITUS (Severe itching skin lesions developed over the lower abdomen initially, but spread to the neck, trunk and four limbs afterwards) and RASH (Skin rash) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. Treatment medication were not reported.   This case was linked to MODERNATX, INC.-MOD-2023-695829 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2023-695829:Post number 26
Injection site induration and erythema measuring 10.5 x 7 cm. Small blister at center.
Patient experienced hives 3 days after receiving vaccine. Patient received DEPO MEDROL 80 mg in office visit and recommended OTC ALLEGRA.
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Pfizer reviewed the stability of the vaccine you received and determined that it likely did not maintain the activity necessary to protect against COVID-19 at time of administration. Pfizer cannot guarantee the protection you may have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Patient reported 2 to 3 hours post-injection, injection site reaction, localized to injection area being "large red and painful." Followed up with patient in 3 hours and patient reported there was no progression and that the patient was feeling OK.
Large swollen circle under injection site.  Lasted for 5 days.  Still sore to touch.  No swelling as of 10/27/2015.
Slight swelling at the sight of injection (about 7mm in diameter). Redness.
On 11/29/2021 I was sitting at my dining table and felt a whoosh of lightheadedness. I thought I was going to faint, so I called my husband. The feeling passed after 30 min. The following day while lying in bed the same thing happened and lasted about 30 min. The day after that 12/1/2021 I was working and had the same feeling around lunch time. This time the feeling did not go away so I went to urgent care that evening and they said everything looked fine. They told me to follow up with my primary doctor. For the next week, I was not feeling any better, so I went to my doctor on 12/8/2021. She diagnosed me with a kind of sudden vertigo and prescribed Meclizine. I have been taking that daily and it is helping a lot. However, a few days into taking the Meclizine I woke up in the middle of the night and my left arm where I received the vaccine was so swollen and curled into my chest. I called my doctor, and she prescribed a 6-day course of Prednisone which I just finished. My arm feels really good now. In addition to all of this, I took a COVID test today (12/23/2021) and tested positive.
Sweating, chills, extreme headache, stomach cramping, leg aches and restless leg syndrome, severe arm pain, dizziness
2-3 days after rec'ing Zostavax, pt developed pruritic erythematous papules below L axilla, rash then spread to involve upper ches, abdomen and entire back, shoulders, arms.  No fever/chills, myalgias, mouth lesions or swelling, no shortness of breath.
I got the J&J covid vaccine on 4/10/2021 at 11:40am.  Later on that day, my left arm was sore so I took Tylenol.  After my shower that night around 10pm, I felt cold/shaky/chills & had really weird dreams.   The next morning (4/11/2021), I slept in late & was very tired when I woke up.  I also had a headache, fever (100.2F) & nausea. Took 2 Tylenol 500 mg each  & these symptoms went away later that night.   Two days after the vaccine, on 4/12/2021, I woke up with itchy red rashes all over both of my legs & feet (~30 small-med size). Took 2 doses of Zyrtec & Benadryl 50mg twice that day so it wouldn?t itch so much. Also applied mometasone ointment to rashes.   On 4/13/2021, I did a video visit with a doctor.  She said my rashes were probably due to an immune response to the J&J covid vaccine (meaning it is working) & it didn?t look serious since it was only on my legs.  She said to continue the Zyrtec up to 2x/day, Benadryl every 6 hrs if needed, & apply mometasone steroid ointment for the rashes 1x/day.  On 4/14/2021, the rashes have improved and I had less than 10 rashes on my legs.  Since I still had some rashes, I continued to take 1 Zyrtec 10mg in the morning & applied mometasone ointment to the rashes.   On 4/16/2021, the rashes had resolved.
Fever up to 102° started around midnight - took Tylenol which lowered the fever and stopped the chills for a while Chills started at midnight  Headache started next morning  Muscle pain/tightness started around 3:00 AM  first night  Weakness started around midnight
Chills; Temperature of 100; A report was received from a consumer concerning a  female patient who experienced Chills and Fever.   The patient reporter, included no any historical conditions. No relevant concomitant medications were reported.   After the first dose of mRNA-1273,  Adverse event was reported which is crosslinked to MOD21-01675. There was no change planned to the dosing schedule of mRNA-1273 in response to the events.  The patient received their second of two planned doses of mRNA-1273 vaccine on 26 JAN 2021 for prophylaxis of COVID-19 infection.   It was reported that she experienced chills and a temperature of 100 after receiving her second dose on 26Jan2021. No treatment information was provided.     The patient received both scheduled doses of mRNA-1273 prior to this  events The outcome of the events were unknown.
It went into a cough gradually and somewhat of a fever; I was getting over it when I came down with another fever with a cough you could not get over; sounds in my throat (like the windpipe); weak too, very weak; It went into a cough gradually and somewhat of a fever; I was getting over it when I came down with another fever with a cough you could not get over; throat is a little itching; terrible sore throat; This spontaneous report refers to a 67-year-old male patient, who was reporting on himself. The patient's concomitant therapies included unspecified blood thinner. His drug reactions or allergies included penicillin (unspecified) and acetaminophen (TYLENOL). No information regarding the patient's pertinent medical history was provided.  On 11-DEC-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, route of administration, lot # and expiration date were not reported) for prophylaxis.  On 13-DEC-2019, the patient experienced a terrible sore throat. It went into a cough gradually and somewhat of a fever. He was very weak too. The patient was getting over it when he came down with another fever with a cough which he could not get over on an unspecified date. When he breathed in, there were sounds in his throat like the windpipe. On an unknown dates, the patient took cetirizine hydrochloride (+) pseudoephedrine hydrochloride (ZYRTEC-D), eucalyptus oil (+) menthol (FISHERMAN'S FRIEND) and diphenhydramine hydrochloride (BENADRYL) for cough. On 20-FEB-2020, the patient reported his throat was a little itching.  The outcome of the events "terrible sore throat, it went into a cough gradually and somewhat of a fever, he was very weak too" was reported as recovering. The outcome of "another fever with a cough, throat is a little itching and sounds in my throat" was unknown. The causality assessment between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: patient fainted from seated position. no injury. patient has recovered completely and currently experiencing no symptoms.
She was admitted on 4/29 for altered mental status. She received her second dose of COVID vaccination on 4/27 at 0700 and her son reported that 2h after the vaccination she started to act strange with labile mood, but mostly intermittently tearful. Later that evening after 5pm she became confused (at times not recognizing who her son was) with worsening intermittent agitation, labile moods, singing, and reporting visual hallucinations. Denied SOB, chest pain, fevers, chills, n/v/d, new medications... Per son she is A&Ox4 at baseline and no history of mental illnesses.
Pfizer-BioNTech COVID-19 Vaccine EUA was administered at 1 pm. Within 10 minutes or less, my vision blurred and the store darkened and felt like it was closing in. I felt dizzy and nausea. I sat down away from people and let someone know. I got a pink in my eyes and some parts of my body. I waited about 45 minutes and my vision cleared and the dizziness faded considerably. The nausea remained and some pinkness remained. Slight headache off and on for two days. Had minor discomfort for two days.
Tingling in arm, anxiety , refused to fo with EMT.  We gave her Benadryl and monitored for 45 minutes, she got better and went home
lymph nodes so big hard to swallow on left side and could not lay down; lymph nodes so big hard to swallow on left side and could not lay down; sore arm/arm hurt badly; couldn't sleep/hard to sleep; felt right side of body start to swell/Neck underarm shoulder; Painful lymph nodes/tender nodes; diarrhea through tout day; sore muscles; Tired low energy; Tired low energy; bad headache all over head; This is a spontaneous report from a contactable consumer who reported about self that a patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in upper right arm on an unspecified date at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was reported that Thursday 10:00 vaccine upper right arm. Felt fine very sore arm couldn't sleep because arm hurt badly. Friday went for easy walk at around 1:30 and felt right side of body start to swell. Neck underarm shoulder patient took 400 mg ibuprofen (MOTRIN). Took MOTRIN again before bed. Painful lymph nodes hard to sleep with MOTRIN. Saturday lymph nodes painful and diarrhea through tout day and evening sore muscles. Tired low energy. Saturday night lymph nodes so big hard to swallow on left side and could not lay down. Took 800 mg MOTRIN and was able to swallow better. And able to sleep with mild pain. Sunday lymph nodes decreased in pain and size. Was feeling better as day went on. Took MOTRIN for bed diarrhea stopped. Monday woke up with bad headache all over head. And still tender nodes but decreased in size. Patient went to doctors to make sure it wasn't something else. Doctor confirmed vaccine immune response. Return in 2 weeks. Outcome of the event diarrhea was recovered/resolved; of headache was unknown; while of remain was recovering/resolving.  Information on the lot/ batch number has been requested.
Female patient received and expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 22-year-old female patient who received Men B NVS (Bexsero) (batch number ABXA82AZ, expiry date 31st January 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 18th February 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 18th February 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient received an expired dose of Bexsero, which led to expired vaccine used. The reporter declined to provide her last name and the patient's date of birth but did state that, the patient was 22 years old.  The reporter consented to follow up.
large red area (1 1/2-2" in diameter) around inj site for approx 2wk;area was swollen, hard, & felt hot to touch;area itched quite a bit for 2 to 3 wk p/inj;
Warm - No fever, just very warm with a red face Muscle fatigue and soreness General fatigue from using any muscle... standing... walking...etc. I have no issues at all with performing any of these activities  All symptoms were gone after approximately 36 - 48 hours
This spontaneous report as received from a registered pharmacist refers to a male patient of unknown age. The patient was vaccinated with a dose of live ZOSTAVAX (route and lot # not reported) on an unspecified date. No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that on an unknown date, the patient experienced getting a rash on his scalp and chest. The patient did not receive treatment for the adverse event. The outcome of rash on his scalp and chest was reported as recovered/resolved. The relatedness for rash on his scalp and chest was unknown for live ZOSTAVAX. Additional information has been requested.
Hives all over my body that sometimes tingle when I get hot. They are getting worse everyday. They are slightly raised on my skin and red. I went to the doctors today and I was prescribed prednisone for the next 5 days. Also when working out blood vessels in my neck are popping and this has never been a problem while lifting weights until receiving my second dose
Moderna COVID-19 Vaccine EUA 1/4/21 - Fatigue; pain and redness at injection site; light nausea.  1/5/21 - Nausea in morning; swelling, pain, redness at injection site; minor headache. 1/6/21 - Swelling, pain, redness, itching, hot to touch at injection site (worse than previous day)-looks like a hive; minor headache; slight nausea in evening. 1/7/21 - Arm swelling and redness still present but improving; slight headache. 1/8 - 1/10/ 21 - Arm swelling improving and redness fading. No other symptoms. 1/11/21 - Arm swelling/hardness, redness, itching, hard, hot to touch at injection site returned. Larger, more swollen and redder than before. 1/12/21 - Same as 1/11 symptoms above. Area resembles large red welt.
Pregnant and Received Heplisav-B; Initial report received on 26-May-2023.  A physician's assistant reported that a female (age, race, and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and the patient is pregnant.  No relevant medical history was reported.    No relevant concomitant medications were reported.    On an unspecified date, the patient received a dose of HEPLISAV-B (route, site, lot #, expiration date were not reported, and NDC # 43528-002-01).   On an unspecified date, after having been vaccinated with HEPLISAV-B, the patient was noted to have been pregnant when she was vaccinated.   No additional information was reported.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
SORE BICEP BELOW INJECTION SITE (LITTLE PAIN BELOW THE BICEP); SORE AT INJECTION SITE; This spontaneous report received from a patient concerned an 80 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 18-MAR-2021, the patient experienced sore at injection site. On 19-MAR-2021, the patient experienced sore bicep below injection site (little pain below the bicep). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore at injection site and sore bicep below injection site (little pain below the bicep) was not reported. This report was non-serious.
Pt. received 3 doses Menquadfi: 1/12/23, 4/6/23,10/5/23
3 large blotches on his left arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (3 large blotches on his left arm) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced RASH MACULAR (3 large blotches on his left arm). In 2021, RASH MACULAR (3 large blotches on his left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No Treatment information was reported.   This case was linked to MOD-2021-290094 (Patient Link).
Bruising on left arm at site of injection, tested positive for Covid a week later and had mild symptoms for 3 days (fatigue, muscle aches, headache, sore throat, congestion, cough, sneezing)
3 minuets post vaccination of COVID vaccine and child got dizzy and fell out of chair and was pale. Child denied loosing consciousness.  Placed child on mat, raised feet on chair, placed a cool cloth on forehead, given juice and snacks. Recovered within 10 minuets.
Patient admitted to hospital with being treated with remdesivir and dexamethasone.  COVID 19 Antigen (-) , PCR (+)
Within 15 minutes, post vax, pt reported feeling light-headed and began to have SOB. She then noticed her right arm was red, swollen and hot to touch. She described her arm swelling as being about as big as an orange in diameter and approx. 1 1/2" induration. She states there was a small white circle at actual injection site. Pt took Benadryl and rested lying down for 15-20 minutes and then felt fine. Swelling and redness went away on 8/27/00.
This is a spontaneous report from a contactable consumer reporting for herself. A 22-year-old female patient received second dose of TRUMENBA, via an unspecified route of administration, on 13May2015 at 04:00 PM, at single dose, due to Meningitis outbreak at her university. Medical history and concomitant medications were none. The patient experienced low fever for 8 hours, nausea, like body aches for 2 hours, like hot and cold flashes for 2 hours. The patient was admitted to hospital on 13May2015 4 hours after receiving the vaccine shot. Therapeutic measures were taken as a result of low fever and included treatment with TYLENOL and ADVIL. No treatment was received for like body aches and like hot and cold flashes. No lab tests done. The final outcome of the events was recovered. Follow-up (17Aug2015): new information received from the same contactable consumer includes: seriousness, events details. Follow-up attempts completed. No further information expected.
This spontaneous report was received from an office manager concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On 24-JUL-2017, the patient was inadvertently vaccinated with an expired dose of VARIVAX lot # L026405, expiration date: 15-JUL-2017, as prophylaxis (Strength, dose, and route were not reported). The patient's concomitant therapies included sterile diluent lot # L039104, expiration date : 09-MAY-2018. No adverse effect was reported.
"positive" skin tests using the Fluzone Quadrivalent vaccine; local reactions; Initial information received on 04-Jan-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves an unknown age female patient who experienced "positive" skin tests using the fluzone quadrivalent vaccine and local reactions while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious "positive" skin tests using the fluzone quadrivalent vaccine (skin test positive) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. On an unknown date the patient developed a non-serious local reactions (local reaction) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QUADRIVALENT) was not applicable.  It was not reported if the patient received a corrective treatment for the events ("positive" skin tests using the Fluzone Quadrivalent vaccine, local reactions).  At time of reporting, the outcome was Unknown for the event "positive" skin tests using the fluzone quadrivalent vaccine and was Unknown for the event local reactions.
upper lt arm became inflammed & edematous immed p/vax; arm was extremely tender to touch;arm was iced intermittently throughout the day;pt's pvt physician was notified